Adding genetic testing to the evaluation of pediatric patients with neurodevelopmental disorders (NDD) resulted in more individualized care, including changes in medication, referrals to clinical ...
Management Anticipates That it has Sufficiently Addressed the FDA’s Concerns to Mitigate the Need for a Clinical Data Request ...
From detecting early disease to guiding treatment plans, clinicians are finding ctDNA testing increasingly important.
The engagement with an EU-based GMP manufacturing facility enables timely production and preparation for clinical trial. The EU-based GMP ...
The test used two synovial fluid biomarkers to accurately differentiate osteoarthritis from inflammatory arthritis, but its ...
Broad enrollment criteria appear to have scuttled the trial, which was designed to test whether ctDNA could identify patients ...
Adding genetic testing to the evaluation of pediatric patients with neurodevelopmental disorders (NDD) resulted in more ...
Special Report: Predictive cancer diagnostics company Rhythm Biosciences (ASX:RHY) is ending 2024 on a high reporting it had ...
Despite these limitations, the researchers believe the study highlights the underutilization of Lp (a) testing in US individuals with ASCVD, despite the strong association between elevated Lp (a) ...
Genetic testing, which has expanded in recent years with advances in technology and the development of consumer products, is ...
A novel nanobody-based immunosensor, designed to function stably in undiluted biological fluids and harsh conditions.
Funding from the Children’s Tumor Foundation will enable researchers at the University of Plymouth to pioneer a testing model ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback